A Massachusetts-based biotechnology company announced Monday that it will open a facility in Rockville in the coming years. TCR² Therapeutics Inc., based in Cambridge, is a clinical-stage company that develops T-cell therapies for patients with cancer. In a statement, TCR² said it signed a long-term, full-building lease for an existing 85,000 sq. ft. facility. The […]
TCR² Therapeutics Inc.
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia